A new initiative by Nawaloka Hospitals PLC :  The Haemato-Oncology Unit
Diseases we specialize in treating and managing long-term
Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, or a red scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin. In those who have been diagnosed with cancer, a number of treatments may be used, including surgery, radiation therapy, chemotherapy, hormonal therapy and targeted therapy. Types of surgery vary from breast-conserving surgery to mastectomy. Breast reconstruction may take place at the time of surgery or at a later date. In those in whom the cancer has spread to other parts of the body, treatments are mostly aimed at improving quality of life and comfort.
Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. If left untreated, this growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as primary lung cancers, are carcinomas. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains. Treatment options are surgery, Chemo Therapy, Radio therapy, Bronchoscopy and Palliative Care.
Colorectal cancer (also known as colon cancer, rectal cancer, or bowel cancer) is the development of cancer from the colon or rectum (parts of the large intestine). It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time.
Most colorectal cancers are due to old age and lifestyle factors with only a small number of cases due to underlying genetic disorders. Some risk factors include diet, obesity, smoking, and lack of physical activity. In both cancer of the colon and rectum, chemotherapy may be used in addition to surgery in certain cases. The decision to add chemotherapy in management of colon and rectal cancer depends on the stage of the disease.
Prostate cancer, also known as carcinoma of the prostate, is the development of cancer in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, some grow relatively quickly. The cancer cells may spread from the prostate to other parts of the body, particularly the bones and lymph nodes. It may initially cause no symptoms. In later stages it can lead to difficulty urinating, blood in the urine, or pain in the pelvis, back or when urinating. A disease known as benign prostatic hyperplasia may produce similar symptoms. Other late symptoms may include feeling tired due to low levels of red blood cells. At present, an active area of research and non-clinically applied investigations involve non-invasive methods of prostate tumor detection. Treatment of aggressive prostate cancers may involve surgery (i.e. radical prostatectomy), radiation therapy including brachytherapy (prostate brachytherapy) and external beam radiation therapy, high-intensity focused ultrasound (HIFU), chemotherapy, oral chemotherapeutic drugs (Temozolomide/TMZ), cryosurgery, hormonal therapy, or some combination.
Acute Leukaemia :
Acute Leukaemias are aggressive blood cancers which may affect both adults and children. The prognosis of acute leukaemia depends on the patients’ age and specific abnormalities in the genes of the leukaemia cells. Chemotherapy is the main treatment for acute leukaemia with some patients requiring a stem cell transplant.
Lymphomas are a group of blood cancers which arise from cells of the lymphatic system. Both adults and children can be affected by lymphoma. The prognosis of lymphoma depends on the patients age, subtype of lymphoma and stage of the disease. Chemotherapy and immunotherapy ( antibody drugs) are the mainstay of treatment while radiotherapy also has a role in some types of lymphoma. Many patients with lymphoma enjoy a good prognosis with the latest treatment modalities.
Multiple myeloma is a blood cancer which arises from a type of white blood cell called a plasma cell in the bone marrow. Multiple myeloma affects mainly adults, the prognosis of multiple myeloma depends on genetic changes in the plasma cells. With the latest treatment ,patients with multiple myeloma can expect prolonged periods of disease control and a good quality of life.
Myelodysplastic syndromes (MDS) are a group of blood disorders characterized by abnormal maturation of young blood cells in the bone marrow. MDS mainly affects adults, the prognosis of MDS varies depending on the subtype and genetic changes in the blood cells. Some patients with MDS may progress to acute myeloid leukaemia.
Myeloproliferative Neoplasms ( MPN) are a group of blood disorders where there is abnormal proliferation of blood cells. Polycythaemia Vera, Essential Thrombocytosis, Chronic Myeloid Leukaemia and Myelofibrosis are the disorders classified under the MPN group. Significant advances in the diagnosis and treatment of these disorders have been made in the recent past.
The new haemato-oncology unit aims to provide patients high quality diagnostics and treatment based on the latest international standards at an affordable price.
For more information on our services please contact our appointment line to make an appointment with a specialist.
Dr. Sanjay de Mel
Specialist Clinical Haematologist
BSc ( Hons), BM ( Hons), MRCP (UK), FRCPath ( Haematology) UK.
Dr. Sanjay de Mel underwent general medical training at the Southampton University Hospitals UK and the National University Hospital Singapore. He subsequently completed advanced specialist training in clinical haematology at the National University Cancer Institute under the National University Health System Singapore. He is a member of the Royal College of Physicians and a fellow of the Royal College of Pathologists of the United Kingdom. His clinical and research interests are in haematologic malignancies
Dr. Dehan Gunasekera
Consultant in Medical & Radiation Oncology
MBBS DCH MD(Oncology).
Dr. Dehan Gunasekera underwent Oncology training at the National Cancer Institute of Sri Lanka and The Middlesex Hospital, University College London(UCL) in the United Kingdom. Both the National Cancer Institute of Sri Lanka and The Middlesex Hospital, Unversity College London(UCL) in the United Kingdom are premier Cancer treatments centers in Sri Lanka and the United Kingdom respectively .He was first attached to the Teaching Hospital Karaptiya ,Galle which is affiliated to the Medical Faculty, University of Ruhuna. He subsequently moved to the National Cancer Institute of Sri Lanka in 2007 where he continues to work at present, in addition to his work at Nawaloka hospital. His clinical and research interests are in Breast Cancer ,Colorectal Cancers ,Lung Cancer and Prostate Cancer.